TY  - JOUR
AU  - Martínez-Sanz, Javier
AU  - Ron, Raquel
AU  - Moreno, Elena
AU  - Sánchez-Conde, Matilde
AU  - Muriel, Alfonso
AU  - López Cortés, Luis Fernando
AU  - Blanco, José Ramón
AU  - Pineda, Juan Antonio
AU  - Mena, Álvaro
AU  - Calzado Isbert, Sonia
AU  - Moreno, Santiago
AU  - Serrano-Villar, Sergio
PY  - 2022
DO  - 10.3389/fimmu.2022.873408
UR  - http://hdl.handle.net/10668/20583
T2  - Frontiers in immunology
AB  - The initiation of antiretroviral treatment based on a 2-drug regimen (2DR) with dolutegravir plus lamivudine has demonstrated non-inferior efficacy than dolutegravir-based three-drug regimens (3DR). We aimed to assess whether the treatment initiation...
LA  - en
KW  - CD4/CD8 ratio
KW  - HIV
KW  - antiretroviral therapy
KW  - dual therapy
KW  - integrase inhibitors
KW  - Adult
KW  - Amides
KW  - Anti-HIV Agents
KW  - CD8-Positive T-Lymphocytes
KW  - Cohort Studies
KW  - HIV Infections
KW  - HIV-1
KW  - Heterocyclic Compounds, 3-Ring
KW  - Heterocyclic Compounds, 4 or More Rings
KW  - Humans
KW  - Lamivudine
KW  - Oxazines
KW  - Piperazines
KW  - Pyridones
KW  - Tenofovir
TI  - Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV.
TY  - research article
VL  - 13
ER  -